Orchidectomy versus Orchidectomy plus cyproterone acetate in the treatment of metastatic prostatic carcinoma
Medical Journal of Cairo University [The]. 2003; 71 (3): 533-538
em Inglês
| IMEMR
| ID: emr-63667
ABSTRACT
This study included 42 patients all underwent orchidectomy and only 22 received cyproterone acetate in a dose of 150-200 mg PO daily. Clinical, laboratory and radiological evaluations were done during the period of the study [from January 1992 to June 1997 inclusive]. There was no high difference in the causes of death. The mean overall survival was longer in the combined treatment group [44.9 m vs. 36.9 m]. Time to disease progression was significantly longer in the combined modality group [30.7 m vs. 22.7 m]. Hot flushes were less in the combined group [31.0% vs. 60.6%] but the difference was insignificant
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Orquiectomia
/
Taxa de Sobrevida
/
Resultado do Tratamento
/
Acetato de Ciproterona
/
Metástase Neoplásica
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Med. J. Cairo Univ.
Ano de publicação:
2003
Similares
MEDLINE
...
LILACS
LIS